Could these FTSE 100 giants boost your portfolio higher?

Should you be buying these three FTSE 100 (INDEXFTSE: UKX) stocks for their income potential?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

FTSE 100 (INDEXFTSE: UKX) stocks can provide great returns for investors. Through income and growth the stocks can be a stable way to get rich slowly. 

Commodity giant

Glencore (LSE: GLEN) has been under the spotlight for over a year now. Commodity prices across the board fell sharply, which dragged the share price of Glencore down to all-time lows. However, since then the company has done a lot counter criticism of its business and it has come a long way since City analysts were saying it could go to zero. Since 1 January the share price has climbed 125% and analysts are now tagging the stock with price targets over 250p. The company has looked at the issue of its debt pile and divested a number of assets to pay off debt. I believe that the major mining company could be a good way to ride strengthening commodity prices that many expect in the next few years. The stock is coming from a very low price so it could see an explosive price rise soon. 

Defensive pharma

GlaxoSmithKline (LSE: GSK) is a favorite of UK income fund managers and quite rightly so. It holds great defensive qualities and I believe it has less risk than its FTSE 100 peer AstraZeneca. Glaxo shares are currently yielding over 4%, which is a decent income considering we live in a world of low interest rates. For income investors this looks like a top stock to own for its dividend and growth potential. The pipeline of new drugs that Glaxo has is very encouraging and the company believes there could be multiple blockbuster drugs on the way. This pipeline will add to profitability for the firm. While currently the shares are trading on 17 times forward price-to-earnings, Glaxo looks set to reap the rewards of its R&D success and I think the shares look cheap. 

UK housebuilding play

Persimmon (LSE: PSN) is about to become a great income stock due to the huge dividend scheme the company is about to begin. The shares are on a yield of over 5% and have nearly recovered since the Brexit vote shock. The UK has a fundamental housing shortage, which was addressed by Chancellor Philip Hammond this week. When setting out his new £5bn housing fund he said “my message today is clear: it’s time to get building”. This fund is for small businesses to build 25,000 homes by 2020 and 225,000 in the longer term. This is a clear indication that the housebuilding sector in the UK has a lot of work to do. Persimmon is a great way to play housebuilding in the UK and receive some income at the same time. 

I believe that these three giants will provide investors with good capital growth over the next few years and should outperform the wider market. In the case of Glaxo and Persimmon, investors will receive some chunky dividend payouts too. 

Jack Dingwall has no position in any shares mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. The Motley Fool UK has recommended AstraZeneca. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Group of young friends toasting each other with beers in a pub
Investing Articles

FTSE 100 shares: has a once-a-decade chance to build wealth ended?

The FTSE 100 index has had a strong 2025. But that doesn't mean there might not still be some bargain…

Read more »

Passive income text with pin graph chart on business table
Investing Articles

I asked ChatGPT for its top passive income ideas for 2026 and it said…

Stephen Wright is looking for passive income ideas for 2026. But can asking artificial intelligence for insights offer anything valuable?

Read more »

Woman riding her old fashioned bicycle along the Beach Esplanade at Aberdeen, Scotland.
Investing Articles

Here’s how a 10-share SIPP could combine both growth and income opportunities!

Juggling the prospects of growth and dividend income within one SIPP can take some effort. Our writer shares his thoughts…

Read more »

Tabletop model of a bear sat on desk in front of monitors showing stock charts
Investing Articles

The stock market might crash in 2026. Here’s why I’m not worried

When Michael Burry forecasts a crash, the stock market takes notice. But do long-term investors actually need to worry about…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

Is this FTSE 250 retailer set for a dramatic recovery in 2026?

FTSE 250 retailer WH Smith is moving on from the accounting issues that have weighed on it in 2025. But…

Read more »

Young Black woman using a debit card at an ATM to withdraw money
Investing Articles

I’m racing to buy dirt cheap income stocks before it’s too late

Income stocks are set to have a terrific year in 2026 with multiple tailwinds supporting dividend growth. Here's what Zaven…

Read more »

ISA Individual Savings Account
Investing Articles

Aiming for a £1k passive income? Here’s how much you’d need in an ISA

Mark Hartley does the maths to calculate how much an investor would need in an ISA when aiming for a…

Read more »

Two business people sitting at cafe working on new project using laptop. Young businesswoman taking notes and businessman working on laptop computer.
Investing Articles

Is investing £5,000 enough to earn a £1,000 second income?

Want to start earning a second income in the stock market? Zaven Boyrazian breaks down how investors can aim to…

Read more »